Skip to main content
. 2016 Nov 30;12(11):e1006449. doi: 10.1371/journal.pgen.1006449

Fig 1. Schematic outline of the study.

Fig 1

(A) Primary human hepatocytes were treated with either vehicle control, 2.5mM metformin or 40uM compound C + 2.5mM metformin for 8 hours and then subjected to RNA-seq and ChIP-seq. (B) Table showing the number of peaks obtained for each antibody and condition.